IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Paradigm Biocapital Advisors LP

Q3 2023 Holdings

Filed 2023-11-14 | 31 holdings | $1.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Legend Biotech Corp(LEGN)SPONSORED ADS52490G102$136.1M2,025,4809.2%
Argenx SE(ARGX)SPONSORED ADR04016X101$128.5M261,4438.7%
Arcellx Inc(ACLX)COMMON STOCK03940C100$106.0M2,953,1227.2%
Olema Pharmaceuticals Inc(OLMA)COM68062P106$96.4M7,803,6006.5%
Nuvalent Inc(NUVL)COM670703107$75.3M1,638,1475.1%
Bicycle Therapeutics PLC(BCYC)SPONSORED ADS088786108$73.2M3,642,3075.0%
Mirati Therapeutics Inc(MRTXEUR)COM60468T105$72.7M1,668,1164.9%
Immunocore Hldgs PLC(IMCR)ADS45258D105$71.9M1,384,6864.9%
United Therapeutics Corp del(UTHR)COM91307C102$69.4M307,3144.7%
Crinetics Pharmaceuticals in(CRNX)COM22663K107$64.8M2,178,7374.4%
Disc Medicine Inc(IRON)COM254604101$59.8M1,272,2794.1%
Viridian Therapeutics Inc(VRDN)COM92790C104$56.5M3,681,7473.8%
Cerevel Therapeutics Hldng I(CERE1EUR)COM15678U128$55.3M2,532,9723.8%
Incyte Corp(INCY)COM45337C102$52.7M912,4973.6%
Xenon Pharmaceuticals Inc(XENE)COM98420N105$51.0M1,491,8353.5%
Ambrx Biopharma IncSPONSORED ADS02290A102$40.1M3,488,5962.7%
Syndax Pharmaceuticals Inc(SNDX)COM87164F105$34.7M2,390,0772.4%
Autolus Therapeutics PLC(AUTL)SPON ADS05280R100$33.6M14,406,7822.3%
TG Therapeutics Inc(TGTX)COM88322Q108$30.3M3,619,0152.1%
ZAI LAB LTD(ZLAB)ADR98887Q104$27.8M1,142,3831.9%
Alpine Immune Sciences Inc(NVLSEUR)COM02083G100$27.7M2,421,7431.9%
Immatics N.v(IMTX)SHSN44445109$23.8M2,058,4471.6%
Verona Pharma PLC(VRNA)SPONSORED ADS925050106$15.1M926,4321.0%
Caribou Biosciences Inc(CRBU)COM142038108$14.1M2,944,5131.0%
VOR Biopharma IncCOM929033108$13.7M6,461,4670.9%
Roivant Sciences LTD(ROIV)SHSG76279101$12.6M1,081,7670.9%
Kura Oncology Inc(KURA)COM50127T109$11.1M1,212,8280.8%
Compass Pathways PLC(CMPS)SPONSORED ADS20451W101$10.1M1,358,7090.7%
89Bio Inc(ETNBGBP)CallCOM282559103$5.1M329,1000.3%
Ambrx Biopharma IncCallSPONSORED ADS02290A102$2.4M209,6000.2%
Cogent Biosciences Inc(COGT)COM19240Q201$2.2M225,6050.1%